ArkeaBio Corp.

ArkeaBio Names Frank Wooten CEO, Closes A1 Funding

Expanded leadership team and funding will help scale ArkeaBio’s simple, cost-effective solution for farmers and producers to reduce emissions and enhance livestock productivity. BOSTON, MA, USA. Sept. 23, 2025 — ArkeaBio, a global agricultural bioscience company developing the first vaccine to…

ArkeaBio Names Synbio Pioneer Zach Serber CTO

Dr. Serber will advance the biotechnology enabling ArkeaBio’s first-of-its-kind solution to deliver a practical, cost-effective way for farmers and producers to reduce emissions and enhance livestock productivity.   Dr. Serber’s appointment comes as ArkeaBio accelerates toward product validation…

Beyond Carbon: Methane Mitigation Strategies for Global Impact

Methane reduction can have a bigger climate impact than carbon dioxide in the short term. Here are four ways to diversify methane mitigation. The post Beyond Carbon: Methane Mitigation Strategies for Global Impact appeared first on ArkeaBio .

Carbon Pulse: US biotech company moves new livestock methane solution closer to market

In a Carbon Pulse article published May 2, 2025, ArkeaBio CEO Colin South talked with Hailey Clarke about how our vaccine‑based approach can finally unlock scalable methane cuts across the 80% of the world’s pasture‑raised cattle. They discussed how the ArkeaBio team is closing in on market entry,…

S&P Global: ArkeaBio to bring methane reduction vaccine to market before 2030

In an S&P Global story published April 15, 2024, ArkeaBio CEO Colin South spoke with Head of Animal Health Joseph Harvey about ArkeaBio’s plans to bring its cattle methane‑reduction vaccine to market by 2030, offering the first scalable, cost‑effective alternative to feed additives. South and…